A mathematical analysis of SELEX

Computational Biology and Chemistry

Volumn 31, Issue 1, 2007, Pages 11-35

  Levine, Howard A ^a   Nilsen Hamilton, Marit ^a  

^a IOWA STATE UNIVERSITY   (United States)

Author keywords

Aptamer; Mathematical analysis; SELEX

Indexed keywords

BIOCHEMISTRY; ENZYME KINETICS; NUCLEIC ACIDS; NUMERICAL ANALYSIS;

APTAMER; MATHEMATICAL ANALYSIS; SELEX;

MOLECULAR BIOLOGY;

LIGAND; NUCLEIC ACID; PROTEIN;

ARTICLE; BIOLOGICAL MODEL; CHEMISTRY; COMBINATORIAL CHEMISTRY; MATHEMATICS; METHODOLOGY; NONLINEAR SYSTEM; PROTEIN BINDING;

LIGANDS; MATHEMATICS; MODELS, BIOLOGICAL; NONLINEAR DYNAMICS; NUCLEIC ACIDS; PROTEIN BINDING; PROTEINS; SELEX APTAMER TECHNIQUE;

EID: 33846889052     PISSN: 14769271     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.compbiolchem.2006.10.002     Document Type: Article

References (44)

1. Berg O.G., and von Hippel P.H. Selection of DNA binding sites by regulatory proteins: statistical mechanical theory and application to operators and promoters. J. Mol. Biol. 193 (1996) 723-750
2. Bock L.C., Griffen L.C., Latham J.A., Vermass E.H., and Toole J.J. Selection of single-stranded DNA molecules that bind and inhibit human thrombin. Nature 355 (1992) 564-566
3. Boyce M., Scott F., Guogas L.M., and Gehrke L. Base-pairing potential identified by in vitro selection predicts the kinked RNA backbone observed in the crystal structure of the alfalfa mosaic virus RNA-coat protein complex. J. Mol. Recognit. 19 (2006) 68-78
4. Cerchia L., Duconge F., Pestourie C., Boulay J., Aissouni Y., Gombert K., Tavitian B., de Franciscis V., and Libri D. Neutralizing aptamers from whole-cell SELEX inhibit the RET receptor tyrosine kinase. PLoS Biol. 3 (2005) e123
5. Cerchia L., Hamm J., Libri D., Tavitian B., and De Franciscis V. Nucleic acid aptamers in cancer medicine. FEBS Lett. 528 (2002) 12-16
6. Chen C.H., Chernis G.A., Hoang V.Q., and Landgraf R. Inhibition of heregulin signaling by an aptamer that preferentially binds to the oligomeric form of human epidermal growth factor receptor-3. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 9226-9231
7. Conrad R., Keranen L.M., Ellington A.D., and Newton A.C. Isozyme-specific inhibition of protein kinase C by RNA aptamers. J. Biol. Chem. 269 (1994) 32051-32054
8. Cui Y., Rajasethupathy P., and Hess G.P. Selection of stable RNA molecules that can regulate the channel-opening equilibrium of the membrane-bound gamma-aminobutyric acid receptor. Biochemistry 43 (2004) 16442-16449
9. DeStefano J.J., and Cristofaro J.V. Selection of primer-template sequences that bind human immunodeficiency virus reverse transcriptase with high affinity. Nucleic Acids Res. 34 (2006) 130-139
10. Djordjevic M., and Sengupta A.M. Quantitative modeling and data analysis of SELEX experiments. Phys. Biol. 3 13 (2006) 13-28
11. Ellington A.D., and Szostak J.W. In vitro selection of RNA molecules that bind specific nucleic acids. Nature 346 (1990) 818-822
12. Eulberg D., Buchner K., Maasch C., and Klussmann S. Development of an automated in vitro selection protocol to obtain RNA-based aptamers: identification of a biostable substance P antagonis. Nucleic Acids Res. 22 (2005) e45
13. Fan X., Shi H., Adelman K., and Lis J.T. Probing TBP interactions in transcription initiation and reinitiation with RNA aptamers that act in distinct modes. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 6934-6939
14. Gening L.V., Klincheva S.A., Reshetnjak A., Grollman A.P., and Miller H. RNA aptamers selected against DNA polymerase beta inhibit the polymerase activities of DNA polymerases beta and kappa. Nucleic Acids Res. 34 (2006) 2579-2586
15. German I., Buchanan D.D., and Kennedy R.T. Aptamers as nucleic acids in affinity probe capillary electrophoresis. Anal. Chem. 70 (1998) 4540-4545
16. Gopinath S.C., Misono T.S., Kawasaki K., Mizuno T., Imai M., Odagiri T., and Kumar P.K. An RNA aptamer that distinguishes between closely related human influenza viruses and inhibits haemagglutinin-mediated membrane fusion. J. Gen. Virol. 87 (2006) 479-487
17. Irvine D., Tuerk C., and Gold L. SELEXION, systematic evolution of nucleic acids by exponential enrichment with integrated optimization by non-linear analysis. J. Mol. Biol. 222 (1991) 739-761
18. Jarosch K., Buchner S., and Klussmann. Short bioactive Spiegelmers to migraine-associated calcitonin gene-related peptide rapidly identified by a novel approach: tailored-SELEX. Nucl. Acids Res. 31 (2004) e130
19. Kim Y.M., Choi K.H., Jang Y.J., Yu J., and Jeong S. Specific modulation of the anti-DNA autoantibody-nucleic acids interaction by the high affinity RNA aptamer. Biochem. Biophys. Res. Commun. 300 (2003) 516-523
20. Kulbachinskiy A., Feklistov A., Krasheninnikov I., Goldfarb A., and Nikiforov V. Aptamers to Escherichia coli core RNA polymerase that sense its interaction with rifampicin, sigma-subunit and GreB. Eur. J. Biochem. 271 (2004) 4921-4931
21. Lee S.K., Park M.W., Yang E.G., Yu J., and Jeong S. An RNA aptamer that binds to the beta-catenin interaction domain of TCF-1 protein. Biochem. Biophys. Res. Commun. 327 (2005) 294-299
22. Lee S.Y., and Jeong S. In vitro selection and characterization of TCF-1 binding RNA aptamers. Mol. Cells 17 (2004) 174-179
23. Levitan B. Models and search strategies for applied molecular evolution. Annu. Rep. Comb. Chem. Mol. Div. 1 (1997) 1-72
24. McCabe W.L., Smith J.C., and Harriott P. Unit Operations of Chemical Engineering. 5th ed. (2001), McGraw-Hill, New York
25. Mi J., Zhang X., Giangrande P.H., McNamara J.O., Nimjee S.M., Sarraf-Yazdi S., Sullenger B.A., and Clary II B.M. Targeted inhibition of alpha-beta3 integrin with an RNA aptamer impairs endothelial cell growth and survival. Biochem. Biophys. Res. Commun. 338 (2005) 956-963
26. Mochizuki K., Oguro A., Ohtsu T., Sonenberg N., and Nakamura Y. High affinity RNA for mammalian initiation factor 4E interferes with mRNA-cap binding and inhibits translation. RNA 11 (2005) 77-89
27. Moreno M., Rincon E., Pineiro D., Fernandez G., Domingo A., Jimenez-Ruiz A., Salinas M., and Gonzalez V.M. Selection of aptamers against KMP-11 using colloidal gold during the SELEX process. Biochem. Biophys. Res. Commun. 308 (2003) 214-218
28. Mori T., Oguro A., Ohtsu T., and Nakamura Y. RNA aptamers selected against the receptor activator of NF-kappaB acquire general affinity to proteins of the tumor necrosis factor receptor family. Nucl. Acids Res. 32 (2003) 6120-6128
29. Ogawa A., Tomita N., Kikuchi N., Sando S., and Aoyama Y. Aptamer selection for the inhibition of cell adhesion with fibronectin as target. Bioorg. Med. Chem. Lett. 4 (2004) 4001-4004
30. Pileur F., Andreola M.L., Dausse E., Michel J., Moreau S., Yamada H., Gaidamakov S.A., Crouch R.J., Toulme J.J., and Cazenave C. Selective inhibitory DNA aptamers of the human RNase H1. Nucl. Acids Res. 31 (2003) 5776-5788
31. Pollard J., Bell S.D., and Ellington A.D. Generation and use of combinatorial libraries. In: Ausubel G., Brent F.M., Kingston R., Moore, R.E., Seidman D.D., Smith, J.G., and Struhl K. (Eds). Current Protocols in Molecular Biology, vol. 4 (2000), Greene Publishing Associates, John Wiley Liss & Sons, Inc., New York, NY, USA pp. 24.21.21-24.25.34
32. ′-fluoro-RNA aptamers that bind preferentially to disease-associated conformations of prion protein and inhibit conversion. J. Biol. Chem. 278 (2003) 39697-39705
33. Skrypina N.A., Savochkina L.P., and Beabealashvilli R. In vitro selection of single-stranded DNA aptamers that bind human pro-urokinase. Nucleos. Nucleot. Nucl. Acids 23 (2004) 891-893
34. Stormo G.D., and Yoshioka M. Specificity of the mnt protein determined by binding to randomized operators. Proc. Natl. Acad. Sci. U.S.A. 88 (1991) 5699-5703
35. Sun F., Galas D., and Waterman M.S. A mathematical analysis of in vitro molecular selection-amplification. J. Mol. Biol. 258 4 (1996) 650-660
36. Surugiu-Warnmark I., Warnmark A., Toresson G., Gustafsson J.A., and Bulow L. Selection of DNA aptamers against rat liver X receptors. Biochem. Biophys. Res. Commun. 332 (2005) 512-517
37. Tombelli S., Minunni M., and Mascini M. Analytical applications of aptamers. Biosens. Bioelectron. 20 (2005) 2424-2434
38. Tuerk C., and Gold L. Systematic evolution of nucleic acids by exponential enrichment: RNA nucleic acids to bacteriophage T4 DNA polymerase. Science 249 (1990) 505-510
39. Vo N.V., Oh J.W., and Lai M.M. Identification of RNA ligands that bind hepatitis C virus polymerase selectively and inhibit its RNA synthesis from the natural viral RNA templates. Virology 307 (2003) 301-316
40. von Hippel P.H., and Berg O.G. On the specificity of DNA-protein interactions. Proc. Natl. Acad. Sci. U.S.A. 83 (1986) 1608-1612
41. Wall F.T. Chemical Thermodynamics (1958), W.H. Freeman, San Francisco
42. White R.R., Shan S., Rusconi C.P., Shetty G., Dewhirst M.W., Kontos C.D., and Sullenger B.A. Inhibition of rat corneal angiogenesis by a nuclease-resistant RNA aptamer specific for angiopoietin-2. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 5028-5033
43. Yang C., Yan N., Parish J., Wang X., Shi Y., and Xue D. RNA aptamers targeting the cell death inhibitor CED-9 induce cell killing in Caenorhabditis elegans. J. Biol. Chem. 281 (2006) 9137-9144
44. Zhou B., and Wang B. Pegaptanib for the treatment of age-related macular degeneration. Exp. Eye Res. 83 (2006) 615-619